Bolderbio.com

Bolderbio.com has Server used 66.226.70.28 IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2000-09-14 (20 years, 218 days) and hosted in Fort Lauderdale United States, server ping response time 54 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Bolderbio keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Bolder bio
2 Bolder biopath
3 Bolder biotechnology
4 Bolder biopath address
5 Bolder biopath inc. colo
6 Boulder bio
7 Boulder biomed
8 Boulder biotech
9 Boulder biologic

Hosting Provider

Website: Bolderbio.com
Hostname: 66.226.70.28
Country:
Region: FL
City: Fort Lauderdale
Postal Code: 33301
Latitude: 26.120899200439
Longitude: -80.127296447754
Area Code: 954
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Mozing.xyz (1 seconds ago)

   » Erre2017.com (18 seconds ago)

   » Coachingforchange.com (0 seconds ago)

   » Jourdansbridge.com (20 seconds ago)

   » Divineorchidflorist.com (1 seconds ago)

   » Regionalfinance.com (27 seconds ago)

   » Choisir.com (0 seconds ago)

   » Bolderbio.com (0 seconds ago)

   » Coachingactuaries.com (18 seconds ago)

   » Servion.com (6 seconds ago)

Results For Websites Listing

Found 45 Websites with content related to this domain, It is result after search with search engine

Bolder BioTechnology Announces Positive Preclinical Data

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 68

  • is a private company developing treatments for life-threatening diseases
  • Additional information can be found at www.bolderbio.com.

Bolder BioTechnology, Inc.

Cmocro.com   DA: 14 PA: 48 MOZ Rank: 63

  • is a clinical stage protein therapeutics company dedicated to providing patients with easier to use, safer, and more cost effective treatments for their disease.

BOLDER BIOTECHNOLOGY INC · 907 Pikes Peak Ln, Louisville

Opengovus.com   DA: 13 PA: 21 MOZ Rank: 36

  • BOLDER BIOTECHNOLOGY INC (DUNS #004603163) is an entity registered with System for Award Management (SAM)
  • The business registration date is March 1, 2002
  • The address is 907 Pikes Peak Ln, Louisville, CO 80027.

Long-acting EPO Analog For Treating Anemia Associated With

Sbir.gov   DA: 12 PA: 25 MOZ Rank: 40

  • Bolder BioTechnology has created a highly potent, long-acting EPO analog that has a significantly increased circulating half-life and superior efficacy in animal erythropoiesis models compared to EPO
  • Based upon animal studies we anticipate that our long-acting EPO analog will be effective when administered once every 4-8 weeks in humans.

Long-acting Growth Hormone For Treating HIV-Associated

Sbir.gov   DA: 12 PA: 25 MOZ Rank: 41

  • DESCRIPTION (provided by applicant): HIV-associated adipose redistribution syndrome (HARS), a form of lipodystrophy, is a common problem in HIV patients on highly active antiretroviral therapy and occurs as a side-effect of their anti-viral drug therapies

Long-acting PEGylated Somatropin

Adisinsight.springer.com   DA: 24 PA: 16 MOZ Rank: 45

A polyethylene glycol (PEG) conjugate of somatropin (somatrogon), designated BBT 031, is being developed by Bolder BioTechnology, for the treatment of growth Long-acting PEGylated somatropin - Bolder BioTechnology - AdisInsight Either you have JavaScript disabled …

Bolder BioTechnology Announces Positive Preclinical Data

Wfmz.com   DA: 12 PA: 50 MOZ Rank: 68

  • 25, 2020 /PRNewswire/ -- Bolder BioTechnology, Inc
  • announced today that preclinical studies have shown that its proprietary long-acting interferon beta analog, BBT-032

A Long-acting, Mono-PEGylated Human Growth Hormone Analog

Ncbi.nlm.nih.gov   DA: 20 PA: 16 MOZ Rank: 43

  • (1)Bolder BioTechnology, Inc., 2945 Wilderness Place, Boulder, Colorado 80301, USA
  • [email protected] Recombinant human GH is used to treat GH deficiency in children and adults and wasting in AIDS patients.

Bolder BioPATH, Inc. LinkedIn

Linkedin.com   DA: 16 PA: 28 MOZ Rank: 52

  • is a contract pharmacology, toxicology and pathology company specializing in In Vivo models of rheumatoid arthritis, osteoarthritis and cancer as well as other autoimmune and

Enhanced Circulating Half-life And Hematopoietic

Pubmed.ncbi.nlm.nih.gov   DA: 23 PA: 10 MOZ Rank: 42

  • Objective: The aim of this study was to determine whether fusion proteins comprising human granulocyte colony-stimulating factor (G-CSF) joined to human immunoglobulin G1 and G4 (IgG1 and IgG4) Fc and C(H) domains are biologically active and have improved pharmacokinetic and hematopoietic properties in vivo
  • Material and methods: Chimeric genes encoding human G-CSF fused to the N-termini of

Working At Bolder Biotechnology Glassdoor

Glassdoor.com   DA: 17 PA: 50 MOZ Rank: 77

  • Glassdoor gives you an inside look at what it's like to work at Bolder Biotechnology, including salaries, reviews, office photos, and more
  • This is the Bolder Biotechnology company profile.

Bolder BioTechnology Announces Positive Preclinical Data

Biospace.com   DA: 16 PA: 50 MOZ Rank: 77

  • is a private company developing treatments for life-threatening diseases
  • Additional information can be found at www.bolderbio.com
  • Forward Looking Statements Statements contained herein that are not historical facts are forward-looking statements that are subject to a variety of risks and uncertainties.

Bolder BioTechnology Announces Positive Results From Phase

Markets.businessinsider.com   DA: 27 PA: 50 MOZ Rank: 89

  • For additional information about Bolder BioTechnology, Inc., please visit our web site at www.bolderbio.com
  • Forward Looking Statements Statements …

Bolder BioTechnology Receives NIH Grant To Advance

Biospace.com   DA: 16 PA: 50 MOZ Rank: 79

  • is a private company using advanced protein engineering and bioconjugation technologies to create proprietary human protein pharmaceuticals with enhanced therapeutic properties
  • Additional information can be found at www.bolderbio

Bolder BioTechnology Announces Initiation Of Phase 1

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 82

  • 2, 2017 /PRNewswire/ -- Bolder BioTechnology, Inc
  • announced today that it has commenced dosing of patients in a Phase 1 clinical trial of its proprietary long-acting

Bolder Biotechnology Inc

Dandb.com   DA: 13 PA: 50 MOZ Rank: 78

Bolder Biotechnology Inc is located at 907 Pikes Peak Ln in Louisville and has been in the business of Medical Laboratories since 1997.

Bolder BioTechnology Announces FDA Orphan Drug Designation

Biopharmaglobal.com   DA: 23 PA: 50 MOZ Rank: 89

  • announced today that its long-acting IL-11 analog, BBT-059, has received Orphan Drug designation from the Food and Drug Administration for treatment of Acute Radiation Syndrome (ARS)
  • Orphan Drug designation is reserved for drugs that treat diseases with fewer than 200,000 patients in the United States
  • Orphan drug designation provides seven years of market

Bolder BioTechnology Receives $1.9 Million NIH Grant To

Medindia.net   DA: 16 PA: 50 MOZ Rank: 83

  • today announced that it has been awarded a $1.9 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Allergy

Long Acting IL-11 Analogue Granted Orphan Drug Status For

Empr.com   DA: 12 PA: 50 MOZ Rank: 80

  • Long Acting IL-11 Analogue Granted Orphan Drug Status for Acute Radiation Syndrome
  • The Food and Drug Administration (FDA) has granted BBT-059 (Bolder Technology) Orphan Drug designation for the

Colorado Biotechs, Medical Firms Get $23M In Federal

Bizjournals.com   DA: 19 PA: 43 MOZ Rank: 81

Colorado biotech and medical device companies won $23 million in federal government grants and tax credits made available under health care reform legislation.

Bolder BioTechnology Announces Initiation Of Phase 1

Pipelinereview.com   DA: 18 PA: 50 MOZ Rank: 88

  • BOULDER, CO, USA I August 2, 2017 I Bolder BioTechnology, Inc
  • announced today that it has commenced dosing of patients in a Phase 1 clinical trial of its proprietary long-acting granulocyte colony-stimulating factor (G-CSF) analog, BBT-015
  • The trial is designed to study the pharmacokinetics, pharmacodynamics, safety and tolerability of single subcutaneous doses of BBT-015 in healthy human

BOLDER BIOTECHNOLOGY: Announces FDA Orphan Drug

Fdahealthnews.com   DA: 17 PA: 50 MOZ Rank: 88

  • is a private company using advanced protein engineering and bioconjugation technologies to create proprietary human protein pharmaceuticals with enhanced therapeutic properties
  • Additional information can be found at www.bolderbio.com
  • Original source can be found here.

A Long-acting, Highly Potent Interferon Alpha-2 Conjugate

Pubmed.ncbi.nlm.nih.gov   DA: 23 PA: 10 MOZ Rank: 55

  • 1 Bolder BioTechnology, Inc., 4056 Youngfield Street, Wheat Ridge, Colorado 80033, USA
  • [email protected]bolderbio.com; PMID: 15656592 DOI: 10.1021/bc049713n Abstract Recombinant interferon alpha-2 (IFN-alpha2) is used clinically to treat a variety of viral diseases and cancers
  • IFN-alpha2 has a short circulating half-life, which necessitates

Bolder BioTechnology Announces Publication Of Data

Pipelinereview.com   DA: 18 PA: 50 MOZ Rank: 91

  • BOULDER, CO, USA I August 28, 2012 I Bolder BioTechnology, Inc
  • announced today publication of preclinical research demonstrating utility of interleukin-11 (IL-11) and the company's long-acting IL-11 analog to prevent kidney damage from ischemia reperfusion injury in mice.This work may lead to new therapeutic approaches to prevent acute kidney injury and ischemia reperfusion injury to multiple

Bolder BioTechnology Announces Publication Of Data

Fiercebiotech.com   DA: 21 PA: 50 MOZ Rank: 95

  • 28, 2012 /PRNewswire/ -- Bolder BioTechnology, Inc
  • announced today publication of preclinical research demonstrating utility of interleukin-11 (IL-11) and the company's long

Bolder BioTechnology Announces Positive Preclinical Data

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 92

  • announced today that preclinical studies have shown that its proprietary long-acting interferon beta analog, BBT-032, strongly inhibits growth of the SARS-CoV-2 virus in

Bolder BioTechnology’s Competitors, Revenue, Number Of

Owler.com   DA: 13 PA: 18 MOZ Rank: 57

  • Bolder BioTechnology's top competitors are Trusted Tablets, Hightimes Holding Corp
  • See Bolder BioTechnology's revenue, employees, and funding info on Owler, the world’s largest community-based business insights platform.

A Long-acting, Mono-PEGylated Human Growth Hormone Analog

Europepmc.org   DA: 13 PA: 21 MOZ Rank: 61

Cloning a cDNA encoding Growth Hormone and Construction of GH (T3C) A cDNA encoding human GH was amplified from human pituitary single-stranded cDNA (CLONTECH, Inc., Palo Alto, CA), using the PCR method ().A periplasmically secreted form of GH was created by using PCR to fuse DNA encoding the signal sequence of the Escherichia coli STII gene to the coding sequence for …

Design, Modeling, Expression, And Chemoselective

Europepmc.org   DA: 13 PA: 20 MOZ Rank: 61

Covalent attachment of PEG to proteins via cysteine residue, known as cysteine PEGylation, is considered an extremely efficient approach to circumventing product heterogeneity and loss of biologic activity characteristic of amine-PEGylation.25 Several grants were allocated to Bolder BioTechnology Inc (www.bolderbio.com) by the National

A Long-Acting, Highly Potent Interferon R-2 Conjugate

Premierlab.com   DA: 14 PA: 45 MOZ Rank: 88

  • A Long-Acting, Highly Potent Interferon r-2 Conjugate Created Using Site-Specific PEGylation Mary S

(PDF) Engineering Cells And Proteins – Creating

Researchgate.net   DA: 20 PA: 50 MOZ Rank: 100

  • The market of pharmaceutically valuable proteins is the fastest growing segment of the economy
  • Most biopharmaceuticals have been obtained in mammalian and microorganism cells, but both systems

Enhanced Circulating Half-life And Hematopoietic

Premierlab.com   DA: 14 PA: 45 MOZ Rank: 90

  • Cox et al./Experimental Hematology 32 (2004) 441–449 longer-acting G-CSF conjugates are improved, although po-tentially not optimized
  • Human IgG1 and IgG4 immunoglobulins, which have circulating half-lives of 21 days in humans [10], have been

(PDF) Hematopoietic Properties Of Granulocyte Colony

Researchgate.net   DA: 20 PA: 50 MOZ Rank: 18

  • Granulocyte colony-stimulating factor (G-CSF) is a 19 kDa
  • protein that stimulates the proliferation, differentiation and

Regulatory Affairs Archives

Biopharmaglobal.com   DA: 23 PA: 32 MOZ Rank: 88

  • Additional information can be found at www.bolderbio.com
  • To Read the Complete Article at PR Newswire, Click Here Disclaimer: BioPharma Global is not responsible for, and expressly disclaims all liability for, damages of any kind arising out of use, reference to, or reliance on any information contained within the article.

Bolder BioTechnology Jobs

Cbinsights.com   DA: 18 PA: 34 MOZ Rank: 86

  • Bolder BioTechnology bolderbio.com
  • Public list: Pharma Startups (6570) Cancer Therapeutics (1180) Dashboard; Performance; Jobs; Investors; Competitors; Patents; Bolder BioTechnology, Inc
  • uses advanced protein engineering technologies to create human protein pharmaceuticals with enhanced therapeutic properties

HireBio Bolder BioTechnology Awarded NIH Phase I SBIR

Hirebio.com   DA: 15 PA: 32 MOZ Rank: 82

  • uses advanced protein engineering technologies to create proprietary, long-acting human protein pharmaceuticals for the treatment of hematopoietic and endocrine disorders, cancer and infectious diseases
  • For additional information about Bolder BioTechnology, Inc., please visit our web site at www.bolderbio.com.

Recently Analyzed Sites

Mozing.xyz (2 seconds ago)

Erre2017.com (19 seconds ago)

Coachingforchange.com (1 seconds ago)

Jourdansbridge.com (21 seconds ago)

Divineorchidflorist.com (2 seconds ago)

Regionalfinance.com (28 seconds ago)

Choisir.com (1 seconds ago)

Bolderbio.com (1 seconds ago)

Coachingactuaries.com (19 seconds ago)

Servion.com (7 seconds ago)

Wovvow.com (14 seconds ago)

Greatlakeswbc.org (17 seconds ago)

Albertabeach.com (15 seconds ago)

Senior-resources.org (20 seconds ago)

Bartondentalcentre.com (7 seconds ago)

Coachingcloud.com (7 seconds ago)